nodes	percent_of_prediction	percent_of_DWPC	metapath
Betahistine—Vasodilation procedure—Irinotecan—colon cancer	0.0327	0.0327	CcSEcCtD
Betahistine—Vasodilation—Irinotecan—colon cancer	0.0327	0.0327	CcSEcCtD
Betahistine—Ventricular extrasystoles—Capecitabine—colon cancer	0.0213	0.0213	CcSEcCtD
Betahistine—Orthostatic hypotension—Irinotecan—colon cancer	0.019	0.019	CcSEcCtD
Betahistine—Abdominal distension—Irinotecan—colon cancer	0.0181	0.0181	CcSEcCtD
Betahistine—Hallucination—Vincristine—colon cancer	0.0147	0.0147	CcSEcCtD
Betahistine—Immune system disorder—Irinotecan—colon cancer	0.013	0.013	CcSEcCtD
Betahistine—Orthostatic hypotension—Capecitabine—colon cancer	0.0127	0.0127	CcSEcCtD
Betahistine—Abdominal pain upper—Capecitabine—colon cancer	0.0127	0.0127	CcSEcCtD
Betahistine—Flatulence—Irinotecan—colon cancer	0.0124	0.0124	CcSEcCtD
Betahistine—Abdominal distension—Capecitabine—colon cancer	0.0121	0.0121	CcSEcCtD
Betahistine—Asthma—Capecitabine—colon cancer	0.0121	0.0121	CcSEcCtD
Betahistine—Bronchospasm—Capecitabine—colon cancer	0.0119	0.0119	CcSEcCtD
Betahistine—Ill-defined disorder—Irinotecan—colon cancer	0.0116	0.0116	CcSEcCtD
Betahistine—Malaise—Irinotecan—colon cancer	0.0113	0.0113	CcSEcCtD
Betahistine—Convulsion—Vincristine—colon cancer	0.0112	0.0112	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.0107	0.0107	CcSEcCtD
Betahistine—Discomfort—Irinotecan—colon cancer	0.0106	0.0106	CcSEcCtD
Betahistine—Anaphylactic shock—Vincristine—colon cancer	0.0105	0.0105	CcSEcCtD
Betahistine—Convulsion—Fluorouracil—colon cancer	0.0104	0.0104	CcSEcCtD
Betahistine—Confusional state—Irinotecan—colon cancer	0.0103	0.0103	CcSEcCtD
Betahistine—Nervous system disorder—Vincristine—colon cancer	0.0103	0.0103	CcSEcCtD
Betahistine—Anaphylactic shock—Irinotecan—colon cancer	0.0102	0.0102	CcSEcCtD
Betahistine—Discomfort—Fluorouracil—colon cancer	0.0101	0.0101	CcSEcCtD
Betahistine—Nervous system disorder—Irinotecan—colon cancer	0.01	0.01	CcSEcCtD
Betahistine—Confusional state—Fluorouracil—colon cancer	0.00989	0.00989	CcSEcCtD
Betahistine—Anaphylactic shock—Fluorouracil—colon cancer	0.00981	0.00981	CcSEcCtD
Betahistine—Nervous system disorder—Fluorouracil—colon cancer	0.00962	0.00962	CcSEcCtD
Betahistine—Tachycardia—Fluorouracil—colon cancer	0.00958	0.00958	CcSEcCtD
Betahistine—Dyspnoea—Irinotecan—colon cancer	0.00913	0.00913	CcSEcCtD
Betahistine—Erythema multiforme—Capecitabine—colon cancer	0.00913	0.00913	CcSEcCtD
Betahistine—Somnolence—Irinotecan—colon cancer	0.00911	0.00911	CcSEcCtD
Betahistine—Gastrointestinal disorder—Vincristine—colon cancer	0.00908	0.00908	CcSEcCtD
Betahistine—Fatigue—Vincristine—colon cancer	0.00907	0.00907	CcSEcCtD
Betahistine—Dyspepsia—Irinotecan—colon cancer	0.00902	0.00902	CcSEcCtD
Betahistine—Asthma—Methotrexate—colon cancer	0.00898	0.00898	CcSEcCtD
Betahistine—Gastrointestinal disorder—Irinotecan—colon cancer	0.00885	0.00885	CcSEcCtD
Betahistine—Fatigue—Irinotecan—colon cancer	0.00883	0.00883	CcSEcCtD
Betahistine—Dyspnoea—Fluorouracil—colon cancer	0.00875	0.00875	CcSEcCtD
Betahistine—Somnolence—Fluorouracil—colon cancer	0.00872	0.00872	CcSEcCtD
Betahistine—Immune system disorder—Capecitabine—colon cancer	0.00872	0.00872	CcSEcCtD
Betahistine—Dyspepsia—Fluorouracil—colon cancer	0.00864	0.00864	CcSEcCtD
Betahistine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00847	0.00847	CcSEcCtD
Betahistine—Feeling abnormal—Irinotecan—colon cancer	0.00844	0.00844	CcSEcCtD
Betahistine—Flatulence—Capecitabine—colon cancer	0.00828	0.00828	CcSEcCtD
Betahistine—Feeling abnormal—Fluorouracil—colon cancer	0.00809	0.00809	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00793	0.00793	CcSEcCtD
Betahistine—Ill-defined disorder—Capecitabine—colon cancer	0.0078	0.0078	CcSEcCtD
Betahistine—Urticaria—Fluorouracil—colon cancer	0.0078	0.0078	CcSEcCtD
Betahistine—Hypersensitivity—Vincristine—colon cancer	0.00775	0.00775	CcSEcCtD
Betahistine—Malaise—Capecitabine—colon cancer	0.00758	0.00758	CcSEcCtD
Betahistine—Hypersensitivity—Irinotecan—colon cancer	0.00755	0.00755	CcSEcCtD
Betahistine—Asthenia—Vincristine—colon cancer	0.00755	0.00755	CcSEcCtD
Betahistine—Asthenia—Irinotecan—colon cancer	0.00735	0.00735	CcSEcCtD
Betahistine—Hypersensitivity—Fluorouracil—colon cancer	0.00723	0.00723	CcSEcCtD
Betahistine—Diarrhoea—Vincristine—colon cancer	0.0072	0.0072	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.0071	0.0071	CcSEcCtD
Betahistine—Discomfort—Capecitabine—colon cancer	0.00707	0.00707	CcSEcCtD
Betahistine—Diarrhoea—Irinotecan—colon cancer	0.00701	0.00701	CcSEcCtD
Betahistine—Dizziness—Vincristine—colon cancer	0.00696	0.00696	CcSEcCtD
Betahistine—Pruritus—Fluorouracil—colon cancer	0.00694	0.00694	CcSEcCtD
Betahistine—Confusional state—Capecitabine—colon cancer	0.00691	0.00691	CcSEcCtD
Betahistine—Erythema multiforme—Methotrexate—colon cancer	0.00679	0.00679	CcSEcCtD
Betahistine—Dizziness—Irinotecan—colon cancer	0.00677	0.00677	CcSEcCtD
Betahistine—Nervous system disorder—Capecitabine—colon cancer	0.00672	0.00672	CcSEcCtD
Betahistine—Diarrhoea—Fluorouracil—colon cancer	0.00671	0.00671	CcSEcCtD
Betahistine—Tachycardia—Capecitabine—colon cancer	0.00669	0.00669	CcSEcCtD
Betahistine—Vomiting—Vincristine—colon cancer	0.00669	0.00669	CcSEcCtD
Betahistine—Skin disorder—Capecitabine—colon cancer	0.00666	0.00666	CcSEcCtD
Betahistine—Rash—Vincristine—colon cancer	0.00663	0.00663	CcSEcCtD
Betahistine—Dermatitis—Vincristine—colon cancer	0.00663	0.00663	CcSEcCtD
Betahistine—Headache—Vincristine—colon cancer	0.00659	0.00659	CcSEcCtD
Betahistine—Vomiting—Irinotecan—colon cancer	0.00651	0.00651	CcSEcCtD
Betahistine—Immune system disorder—Methotrexate—colon cancer	0.00649	0.00649	CcSEcCtD
Betahistine—Dizziness—Fluorouracil—colon cancer	0.00649	0.00649	CcSEcCtD
Betahistine—Rash—Irinotecan—colon cancer	0.00646	0.00646	CcSEcCtD
Betahistine—Dermatitis—Irinotecan—colon cancer	0.00645	0.00645	CcSEcCtD
Betahistine—Headache—Irinotecan—colon cancer	0.00642	0.00642	CcSEcCtD
Betahistine—Nausea—Vincristine—colon cancer	0.00625	0.00625	CcSEcCtD
Betahistine—Vomiting—Fluorouracil—colon cancer	0.00624	0.00624	CcSEcCtD
Betahistine—Rash—Fluorouracil—colon cancer	0.00619	0.00619	CcSEcCtD
Betahistine—Dermatitis—Fluorouracil—colon cancer	0.00618	0.00618	CcSEcCtD
Betahistine—Headache—Fluorouracil—colon cancer	0.00615	0.00615	CcSEcCtD
Betahistine—Dyspnoea—Capecitabine—colon cancer	0.00611	0.00611	CcSEcCtD
Betahistine—Nausea—Irinotecan—colon cancer	0.00609	0.00609	CcSEcCtD
Betahistine—Dyspepsia—Capecitabine—colon cancer	0.00604	0.00604	CcSEcCtD
Betahistine—Gastrointestinal disorder—Capecitabine—colon cancer	0.00592	0.00592	CcSEcCtD
Betahistine—Fatigue—Capecitabine—colon cancer	0.00591	0.00591	CcSEcCtD
Betahistine—Nausea—Fluorouracil—colon cancer	0.00583	0.00583	CcSEcCtD
Betahistine—Ill-defined disorder—Methotrexate—colon cancer	0.0058	0.0058	CcSEcCtD
Betahistine—Feeling abnormal—Capecitabine—colon cancer	0.00565	0.00565	CcSEcCtD
Betahistine—Malaise—Methotrexate—colon cancer	0.00564	0.00564	CcSEcCtD
Betahistine—Urticaria—Capecitabine—colon cancer	0.00545	0.00545	CcSEcCtD
Betahistine—Convulsion—Methotrexate—colon cancer	0.00542	0.00542	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00529	0.00529	CcSEcCtD
Betahistine—Discomfort—Methotrexate—colon cancer	0.00526	0.00526	CcSEcCtD
Betahistine—Confusional state—Methotrexate—colon cancer	0.00515	0.00515	CcSEcCtD
Betahistine—Anaphylactic shock—Methotrexate—colon cancer	0.0051	0.0051	CcSEcCtD
Betahistine—Hypersensitivity—Capecitabine—colon cancer	0.00505	0.00505	CcSEcCtD
Betahistine—Nervous system disorder—Methotrexate—colon cancer	0.00501	0.00501	CcSEcCtD
Betahistine—Skin disorder—Methotrexate—colon cancer	0.00496	0.00496	CcSEcCtD
Betahistine—Asthenia—Capecitabine—colon cancer	0.00492	0.00492	CcSEcCtD
Betahistine—Pruritus—Capecitabine—colon cancer	0.00485	0.00485	CcSEcCtD
Betahistine—Diarrhoea—Capecitabine—colon cancer	0.00469	0.00469	CcSEcCtD
Betahistine—Dyspnoea—Methotrexate—colon cancer	0.00455	0.00455	CcSEcCtD
Betahistine—Somnolence—Methotrexate—colon cancer	0.00454	0.00454	CcSEcCtD
Betahistine—Dizziness—Capecitabine—colon cancer	0.00453	0.00453	CcSEcCtD
Betahistine—Dyspepsia—Methotrexate—colon cancer	0.00449	0.00449	CcSEcCtD
Betahistine—Gastrointestinal disorder—Methotrexate—colon cancer	0.00441	0.00441	CcSEcCtD
Betahistine—Fatigue—Methotrexate—colon cancer	0.0044	0.0044	CcSEcCtD
Betahistine—Vomiting—Capecitabine—colon cancer	0.00436	0.00436	CcSEcCtD
Betahistine—Rash—Capecitabine—colon cancer	0.00432	0.00432	CcSEcCtD
Betahistine—Dermatitis—Capecitabine—colon cancer	0.00432	0.00432	CcSEcCtD
Betahistine—Headache—Capecitabine—colon cancer	0.0043	0.0043	CcSEcCtD
Betahistine—Feeling abnormal—Methotrexate—colon cancer	0.00421	0.00421	CcSEcCtD
Betahistine—Nausea—Capecitabine—colon cancer	0.00407	0.00407	CcSEcCtD
Betahistine—Urticaria—Methotrexate—colon cancer	0.00406	0.00406	CcSEcCtD
Betahistine—Hypersensitivity—Methotrexate—colon cancer	0.00376	0.00376	CcSEcCtD
Betahistine—Asthenia—Methotrexate—colon cancer	0.00366	0.00366	CcSEcCtD
Betahistine—Pruritus—Methotrexate—colon cancer	0.00361	0.00361	CcSEcCtD
Betahistine—Diarrhoea—Methotrexate—colon cancer	0.00349	0.00349	CcSEcCtD
Betahistine—Dizziness—Methotrexate—colon cancer	0.00338	0.00338	CcSEcCtD
Betahistine—Vomiting—Methotrexate—colon cancer	0.00325	0.00325	CcSEcCtD
Betahistine—Rash—Methotrexate—colon cancer	0.00322	0.00322	CcSEcCtD
Betahistine—Dermatitis—Methotrexate—colon cancer	0.00322	0.00322	CcSEcCtD
Betahistine—Headache—Methotrexate—colon cancer	0.0032	0.0032	CcSEcCtD
Betahistine—Nausea—Methotrexate—colon cancer	0.00303	0.00303	CcSEcCtD
